These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse. Stoessl AJ, Dourish CT, Young SC, Williams BJ, Iversen SD, Iversen LL. Neurosci Lett; 1987 Oct 05; 80(3):321-6. PubMed ID: 2446214 [Abstract] [Full Text] [Related]
3. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. Stoessl AJ, Dourish CT, Iversen SD. Psychopharmacology (Berl); 1988 Oct 05; 95(4):502-6. PubMed ID: 2463651 [Abstract] [Full Text] [Related]
4. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats. Stoessl AJ, Dourish CT, Iversen SD. Br J Pharmacol; 1988 Jun 05; 94(2):285-7. PubMed ID: 2456111 [Abstract] [Full Text] [Related]
5. Pharmacological characterization of senktide-induced tail whips. Nordquist RE, Ballard TM, Algeyer B, Pauly-Evers M, Ozmen L, Spooren W. Neuropharmacology; 2010 Jan 05; 58(1):259-67. PubMed ID: 19540857 [Abstract] [Full Text] [Related]
6. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat. Cellier E, Barbot L, Regoli D, Couture R. Br J Pharmacol; 1997 Oct 05; 122(4):643-54. PubMed ID: 9375960 [Abstract] [Full Text] [Related]
7. Effects of ageing on tachykinin function in the basal ganglia. Stoessl AJ, Polanski E, Frydryszak H. Brain Res; 1993 Dec 31; 632(1-2):21-8. PubMed ID: 7511976 [Abstract] [Full Text] [Related]
8. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Fone KC, Johnson JV, Bennett GW, Marsden CA. Br J Pharmacol; 1989 Mar 31; 96(3):599-608. PubMed ID: 2470455 [Abstract] [Full Text] [Related]
14. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. Green AR, Hall JE, Rees AR. Br J Pharmacol; 1981 Jul 31; 73(3):703-19. PubMed ID: 6166345 [Abstract] [Full Text] [Related]
16. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. Sundqvist M, Kristensson E, Adolfsson R, Leffler A, Ahlstedt I, Engberg S, Drmota T, Sigfridsson K, Jussila R, de Verdier J, Novén A, Johansson A, Påhlman I, von Mentzer B, Lindström E. Eur J Pharmacol; 2007 Dec 22; 577(1-3):78-86. PubMed ID: 17920583 [Abstract] [Full Text] [Related]
17. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions. Stoessl AJ, Szczutkowski E, Glenn B, Watson I. Brain Res; 1991 Nov 29; 565(2):254-62. PubMed ID: 1668812 [Abstract] [Full Text] [Related]
20. Inhibitory role on gastric secretion of a central NK-3 tachykinin receptor agonist, senktide. Improta G, Broccardo M. Peptides; 1991 Nov 29; 12(6):1433-4. PubMed ID: 1726124 [Abstract] [Full Text] [Related] Page: [Next] [New Search]